tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

MLTX Stock Latest News

Wolfe upgrades MoonLake Immunotherapeutics ahead of sonelokimab data
The FlyWolfe upgrades MoonLake Immunotherapeutics ahead of sonelokimab data
2d ago
MLTX
MoonLake upgraded to Outperform from Peer Perform at Wolfe Research
PremiumThe Fly
MoonLake upgraded to Outperform from Peer Perform at Wolfe Research
2d ago
MLTX
MoonLake Immunotherapeutics: Buy Rating Driven by Strategic Developments and Promising Clinical Programs
PremiumRatings
MoonLake Immunotherapeutics: Buy Rating Driven by Strategic Developments and Promising Clinical Programs
7d ago
MLTX
MoonLake Immunotherapeutics: Strong Financials and Promising Pipeline Drive Buy Rating
PremiumRatings
MoonLake Immunotherapeutics: Strong Financials and Promising Pipeline Drive Buy Rating
8d ago
MLTX
MoonLake Immunotherapeutics: Strong Financial Position and Promising Data Releases Justify Buy Rating
PremiumRatings
MoonLake Immunotherapeutics: Strong Financial Position and Promising Data Releases Justify Buy Rating
8d ago
MLTX
Promising Growth Potential and Financial Strength Drive Buy Rating for MoonLake Immunotherapeutics
PremiumRatingsPromising Growth Potential and Financial Strength Drive Buy Rating for MoonLake Immunotherapeutics
9d ago
MLTX
MoonLake Immunotherapeutics: Promising Clinical Developments and Market Opportunities Justify Buy Rating
Premium
Ratings
MoonLake Immunotherapeutics: Promising Clinical Developments and Market Opportunities Justify Buy Rating
9d ago
MLTX
MoonLake Immunotherapeutics reports Q1 EPS (63c), consensus (74c)
Premium
The Fly
MoonLake Immunotherapeutics reports Q1 EPS (63c), consensus (74c)
9d ago
MLTX
MoonLake Immunotherapeutics: Promising Clinical Updates and Market Potential Support Buy Rating
PremiumRatings
MoonLake Immunotherapeutics: Promising Clinical Updates and Market Potential Support Buy Rating
20d ago
MLTX
MoonLake Immunotherapeutics price target raised to $85 from $81 at BTIG
PremiumThe Fly
MoonLake Immunotherapeutics price target raised to $85 from $81 at BTIG
21d ago
MLTX
MoonLake Immunotherapeutics: Promising Developments and Financial Strength Justify Buy Rating
PremiumRatings
MoonLake Immunotherapeutics: Promising Developments and Financial Strength Justify Buy Rating
22d ago
MLTX
MoonLake Immunotherapeutics: Promising Developments and Strategic Positioning Justify Buy Rating
PremiumRatings
MoonLake Immunotherapeutics: Promising Developments and Strategic Positioning Justify Buy Rating
22d ago
MLTX
MoonLake Immunotherapeutics: Promising Clinical Trials and Market Potential Drive Buy Rating
PremiumRatingsMoonLake Immunotherapeutics: Promising Clinical Trials and Market Potential Drive Buy Rating
22d ago
MLTX
MoonLake Immunotherapeutics Hosts Capital Markets Day
Premium
Company Announcements
MoonLake Immunotherapeutics Hosts Capital Markets Day
22d ago
8K
MLTX
MoonLake Immunotherapeutics Secures $500M Financing for Growth
Premium
Company Announcements
MoonLake Immunotherapeutics Secures $500M Financing for Growth
2M ago
8K
MLTX
MoonLake Immunotherapeutics secures up to $500M in non-dilutive financing
PremiumThe Fly
MoonLake Immunotherapeutics secures up to $500M in non-dilutive financing
2M ago
HTGC
MLTX
MoonLake Immunotherapeutics’ Sonelokimab Positioned as Leading Treatment for Hidradenitis Suppurativa Amidst Weak JAK Inhibitor Competition
PremiumRatings
MoonLake Immunotherapeutics’ Sonelokimab Positioned as Leading Treatment for Hidradenitis Suppurativa Amidst Weak JAK Inhibitor Competition
2M ago
MLTX
MoonLake Immunotherapeutics initiated with an Outperform at RBC Capital
PremiumThe Fly
MoonLake Immunotherapeutics initiated with an Outperform at RBC Capital
2M ago
MLTX
MoonLake Immunotherapeutics: Advancing Sonelokimab with Promising Phase III VELA Program and Favorable Market Positioning
PremiumRatings
MoonLake Immunotherapeutics: Advancing Sonelokimab with Promising Phase III VELA Program and Favorable Market Positioning
2M ago
MLTX
MoonLake Immunotherapeutics Advances Clinical Trials in 2024
PremiumCompany AnnouncementsMoonLake Immunotherapeutics Advances Clinical Trials in 2024
2M ago
MLTX
MoonLake Immunotherapeutics: Promising Prospects for Sonelokimab in Inflammatory Diseases
Premium
Ratings
MoonLake Immunotherapeutics: Promising Prospects for Sonelokimab in Inflammatory Diseases
2M ago
MLTX
Optimistic Outlook for MoonLake Immunotherapeutics: Promising Developments and Market Opportunities for Sonelokimab
Premium
Ratings
Optimistic Outlook for MoonLake Immunotherapeutics: Promising Developments and Market Opportunities for Sonelokimab
3M ago
MLTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >